Covira is an early-stage biotech company, a spinout from The University of Chicago (Sept 2018). This microbiome-focused company is based on the work of Dr. John Alverdy, MD, a world authority on the molecular basis of post-surgical infections. Covira's focus is to develop drugs that work by modulating the biological activity of the gut microbiome's resident bacteria. Covira’s lead asset (CS-0003) is a platform technology that modulates bacterial virulence and restores microbial communities to prevent post-surgical infection. CS-0003 is transformative to the field and the world is taking notice...in the 4th quarter of last year Business Worldwide Magazine named Covira Among the 2021- Top 20 Most Innovative Companies to Watch.
| Website | https://www.covirasurgical.com/ |
| Employees | 6 (2 on RocketReach) |
| Founded | 2018 |
| Phone | +1 847-680-7174 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+5 more
(view full list)
|
| Industry | Biotechnology Research, Drug Discovery, Biotechnology |
| Keywords | Infection Prevention, Surgical Instruments, Microbiome, Infection Control, Medical Devices, Post Surgical Care, Surgical Equipment, Surgical Procedures, Surgical Supplies, Wound Care, Surgical Technology, Sterile Supplies, Surgical Dressings, Healthcare Technology, Medical Technology, Medical Supplies, Biomedical Devices, Biotechnology, Health Technology |
| Competitors | Medtronic, Johnson & Johnson, Thermo Fisher Scientific, Smith+Nephew, Boston Scientific, B. Braun Group, Stryker, Zimmer Biomet, Impulse Monitoring, Aesculap (US) +42 more (view full list) |
Looking for a particular Covira employee's phone or email?
Jaime Contreras is the Board Member of Covira.
2 people are employed at Covira.
Covira is based in North Chicago, Illinois.